Back to results
US 12,617,813 B2Granted
Glycosylated histone deacetylase inhibitors and methods of making and using the same
AssigneeGeorgia Tech Research Corporation
InventorsAdegboyega Oyelere, Subhasish Tapadar, Bocheng Wu
Life of this patent
Estimating the term…
Abstract
Provided herein are glycosylated compounds as histone deacetylase (HDACi) inhibitors or a diastereomer, solvate, or a pharmaceutically acceptable salt thereof. Also provided are pharmaceutical compositions and medicaments that include the compounds described herein as well as methods of treating inflammatory disease and cancer.
Claims19
A compound of Formula I:
- wherein:
- X is O or NCH3;
- R1 is absent, H, COCH3, CH3, C1-6 alkyl, C1-6 alkanoate, C2-6 carbamate, or C5-6 aryl ester, optionally substituted with heteroatoms;
- R2 and R3 are each independently H, OH or OR4;
- R4 is C1-6 alkyl, C1-6 alkanoate, C2-6 carbamate, or C5-6 aryl ester, optionally substituted with heteroatoms;
- Y is O;
- A is substituted or unsubstituted aryl;
- B is absent or 1,2,3-triazolyl;
- C is C2-8 alkyl, optionally substituted with one or more double bonds;
- D is H, F, OH, OCOCH3, NH2, OR5, or NHR5;
- R5 is C1-6 alkanoate, C2-6 carbamate, C5-6 aryl ester optionally substituted with heteroatoms, or C5-6 fused aryl ester optionally substituted with heteroatoms;
- and
- ZBG is selected from
- wherein Z is halo or heteroaryl;
- or a diastereomer, solvate, or a pharmaceutically acceptable salt thereof.
12 more elements
Dependencies are inferred from the claim text.